Phase 2 Sjogren's Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with primary Sjögren's disease for at least 12 months before the screening visit, and your diagnosis meets the recognised 2016 international classification standards for the condition.
- Your Sjögren's disease is considered moderately to severely active, based on a specific scoring system used by the study doctor at the screening visit.
- A blood test at the screening visit shows you have a specific antibody associated with Sjögren's disease, called SSA/Ro antibody.
- You still produce at least a very small amount of saliva, as measured by a saliva flow test at the screening visit.
Who may not be able to join:
- You have a form of Sjögren's disease that is caused by or linked to another condition, or you have another confirmed autoimmune or inflammatory disease (such as rheumatoid arthritis, lupus, or similar conditions) that the study doctor believes could make it harder to assess your Sjögren's symptoms.
- You have a history of certain blood protein disorders, multiple myeloma, or non-Hodgkin's lymphoma, or you have been diagnosed with any cancer within the last 5 years or currently have an active cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18007970414
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in clinESSDAI Score at Week 24 for IMVT-1402 Dose 1 compared to Placebo
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.